European Pharmaceutical Manufacturer spotlights Daniel O’Keeffe of Qinecsa Solutions in a recent article examining whether patient outcomes are being compromised by fragmented and inconsistent safety data. Daniel highlights the critical need to improve how adverse event data is captured at source, arguing that AI’s greatest value lies in enabling better data collection rather than fixing poor-quality inputs later. He also explores how stronger regulatory direction and more structured reporting approaches could help the industry unlock clearer safety insights and ultimately drive better patient outcomes.
